Author:
Lee Howard,Yang Han-Mo,Lee Hae-Young,Kim Jae-Joong,Choi Dong-Ju,Seung Ki-Bae,Jeon Eun-Seok,Ha Jong-Won,Rim Se-Joong,Park Jeong Bae,Shin Joon-Han,Oh Byung-Hee
Funder
Boryung Pharmaceutical Co, Ltd
Subject
Pharmacology (medical),Pharmacology
Reference35 articles.
1. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT(1)) antagonists;Kim;Bioorg Med Chem Lett,2012
2. Fimasartan;Am J Cardiovasc Drugs,2011
3. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects;Chi;Am J Cardiovasc Drugs,2011
4. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients;Goldberg;Hypertension,1995
5. Valsartan: Preclinical and clinical profile of an antihypertensive angiotensin-II antagonist;Criscione;Cardiovascular Drug Reviews,1995
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献